BODALCHEM
BODALCHEM
BODALCHEM (BODALCHEM) Stock Analysis & Case Study
Is BODALCHEM a good buy? The data-driven verdict.
BODALCHEM (BODALCHEM) trades at ₹69,on the numbers it tread carefully, a Downstox Snapshot Score of 41/100.
On the numbers, BODALCHEM (BODALCHEM) tread carefully, a Downstox Snapshot Score of 41/100, weighing fairly valued at 18.2× earnings, ROE of 4.2%. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027–2031.
Last updated . Data snapshot for research, not investment advice.
BODALCHEM fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
Is BODALCHEM overvalued? BODALCHEM P/E vs its sector
BODALCHEM's P/E of 18.2× sits above the sector peer median of 15.9×, so on earnings it screens richer than peers.
The bull case for BODALCHEM
- A 18.2× P/E sits in the fair-value band, neither cheap nor stretched.
- Low price-to-book of 0.75×, the market is paying little over the company's net assets.
The bear case & risks
- Return on equity is a soft 4.2%, capital efficiency trails higher-quality peers.
- A low Piotroski F-Score of 3/9 flags weaker financial health this cycle, worth understanding why before committing.
BODALCHEM Piotroski F-Score: 3/9, how financially strong is it?
The Piotroski F-Score grades financial strength on nine profitability, leverage and efficiency checks. BODALCHEM scores 3/9,weak on the financial-strength checks.
BODALCHEM MTF margin & leverage, Upstox, Zerodha, Groww, Dhan
Margin Trading Facility lets you buy BODALCHEM with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| DhanCHEAPEST | 64.0% | 1.6× |
Compare every broker on the BODALCHEM MTF page.
BODALCHEM vs peers,sector comparison
About BODALCHEM: sector, index & market-cap context
BODALCHEM (BODALCHEM) is a small-cap NSE-listed company, and a constituent of the Nifty 500 index group, with a market capitalisation of ₹868 Cr. See more Nifty 500 stocks.
How the BODALCHEM Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of BODALCHEM's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
BODALCHEM analysis, FAQs
Is BODALCHEM (BODALCHEM) a good buy?
On the numbers, BODALCHEM (BODALCHEM) tread carefully, a Downstox Snapshot Score of 41/100, weighing fairly valued at 18.2× earnings, ROE of 4.2%. This is a data snapshot for research, not investment advice.
Is BODALCHEM overvalued or undervalued?
BODALCHEM trades at 18.2× earnings versus a peer median of 15.9×, so it screens richer than its sector peers.
What is the bull case for BODALCHEM?
A 18.2× P/E sits in the fair-value band, neither cheap nor stretched. Low price-to-book of 0.75×, the market is paying little over the company's net assets.
What are the risks in BODALCHEM?
Return on equity is a soft 4.2%, capital efficiency trails higher-quality peers. A low Piotroski F-Score of 3/9 flags weaker financial health this cycle, worth understanding why before committing.